Rheumatoid arthritis
Conditions
Interventions
Group 1 :Shock wave
Group 2:MTX, Diclofenac
Sponsors
University Hospital Macau
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. The patient voluntarily signed the informed consent form for this trial; 2. For patients with RA, the NRS score is greater than 3; 3. MRI of the corresponding joints was performed to exclude bone marrow lesions, and the age was 18-65 years old; 4. No nerve block therapy was performed within 1 month before enrollment in this study.
Exclusion criteria
Exclusion criteria: 1. Treatment site infection, hematoma; 2. BP < 90/60 mmHg, HR < 50 beats/min; 3. Coagulation dysfunction; 4. Severe heart, lung, liver and kidney insufficiency; 5. Mental and psychological disorders, unable to clearly express the pain NRS score; 6. Participated in other clinical research within three months; 7. The researcher considers that any reason is unsuitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NAV2 content;Numerical rating scale score;Patient Health Questionnaire-9, PHQ-9 score;Generalized Anxiexy Disorde-7, GAD-7 ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy Evaluation Registration Form; | — |
Countries
China
Contacts
Public ContactMei Zhang
University Hospital, MUST Foundation
Outcome results
None listed